Talisman Therapeutics
Talisman Therapeutics develops disease-modifying therapeutics for Alzheimer's and other neurodegenerative diseases. We also provide access to our revolutionary iPSC platform to support external R&D partnerships.
Private Company
Total funding raised: $34.5M
About
Talisman Therapeutics develops disease-modifying therapeutics for Alzheimer's and other neurodegenerative diseases. We also provide access to our revolutionary iPSC platform to support external R&D partnerships.
Small MoleculesCell & Gene Therapy
Funding History
2Total raised:$34.5M
Series A$32M
Seed$2.5M